imatinib mesylate has been researched along with Cardiovascular Stroke in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlén, T; Dreimane, A; Edgren, G; Flygt, H; Höglund, M; Ljungman, P; Myhr-Eriksson, K; Olsson-Strömberg, U; Richter, J; Själander, A; Stenke, L; Wadenvik, H; Zhao, J | 1 |
| Akiva, A; de Waard, GA; Kea-Te Lindert, M; Konijnenberg, LSF; Kuster, CTA; Luiken, TTJ; Nijveldt, R; Rodwell, L; Thijssen, DHJ; Uthman, L; van Royen, N; Veltien, A | 1 |
| Abruzzese, E; Annunziata, M; Baratè, C; Binotto, G; Bonifacio, M; Breccia, M; Caocci, G; Cattaneo, D; De Gregorio, F; Elena, C; Foà, R; Fozza, C; Galimberti, S; Iurlo, A; La Nasa, G; Luciano, L; Martino, B; Molica, M; Mulas, O; Orlandi, EM; Russo Rossi, A; Sgherza, N; Trawinska, MM | 1 |
| Abell, J; Christian, JB; Cullen, MR; Horwitz, RI | 1 |
| Ahokas, RA; Chen, Y; Liu, C; Liu, H; Meng, W; Sun, Y; Zhao, T; Zhao, W | 1 |
| Drummond, CA; Fan, X; Haller, ST; Liu, J; Malhotra, D; Shi, H; Tian, J | 1 |
| D'Orazio, J; Pulliam, J | 1 |
7 other study(ies) available for imatinib mesylate and Cardiovascular Stroke
| Article | Year |
|---|---|
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.
Topics: Dasatinib; Follow-Up Studies; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myocardial Infarction; Protein Kinase Inhibitors | 2022 |
Imatinib attenuates reperfusion injury in a rat model of acute myocardial infarction.
Topics: Animals; Heart; Imatinib Mesylate; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar | 2023 |
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aniline Compounds; Antineoplastic Agents; Brain Ischemia; Dasatinib; Disease Susceptibility; Drug Administration Schedule; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myocardial Infarction; Nitriles; Peripheral Vascular Diseases; Protein Kinase Inhibitors; Pyrimidines; Quinolines; Retrospective Studies | 2019 |
Medicine. (De)personalized medicine.
Topics: Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Drug Resistance, Neoplasm; Genomics; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Large B-Cell, Diffuse; Myocardial Infarction; Piperazines; Precision Medicine; Pyrimidines | 2013 |
Platelet-derived growth factor blockade on cardiac remodeling following infarction.
Topics: Animals; Benzamides; Fibrosis; Imatinib Mesylate; Lymphokines; Male; Myocardial Infarction; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta1 | 2014 |
Hiding inside? Intracellular expression of non-glycosylated c-kit protein in cardiac progenitor cells.
Topics: Animals; Cell Differentiation; Cell Lineage; Cells, Cultured; Glycosylation; Imatinib Mesylate; Immunohistochemistry; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-kit; Real-Time Polymerase Chain Reaction; Stem Cells; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Hypereosinophilic syndrome presenting as acute myocardial infarction in an adolescent.
Topics: Adolescent; Benzamides; Cerebral Infarction; Drug Therapy, Combination; Electrocardiography; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; Myocardial Infarction; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2011 |